Do Children Have the Same Vulnerability to Metabolic Drug–Drug Interactions as Adults? A Critical Analysis of the Literature
Open Access
- 8 April 2013
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 53 (5) , 559-566
Abstract
Many drug–drug interactions (DDIs) in the pediatric population are managed based on data generated in adults. However, due to developmental changes in elimination pathways from birth to adolesence, and variable weight‐adjusted dose of interacting drugs, the assumption of DDIs being similar in adults and pediatrics might not be correct. This study compares the magnitude of reported DDIs in pediatric and adult populations. A systematic literature review was undertaken to identify reports of DDIs in pediatric subjects. A total of 145 reports of DDIs were identified over the age range of birth to 20 years. The magnitude of DDIs for 24 drug pairs from 31 different pediatric studies could be assessed and compared with those in adults where corresponding data existed. The magnitude of the DDI, as measured by a relevant parameter (e.g., AUC, CL) in the presence and absence of inhibitor, were higher (>1.25‐fold), similar (0.8‐ to 1.25‐fold) or lower (<0.8‐fold) than the corresponding ratio in adults in 10, 15, and 8 cases respectively. An age‐related trend in the magnitude of DDIs could not be established. However, the study highlighted the clear paucity of the data in children younger than 2 years. Care should be exercised when applying the knowledge of DDIs from adults to children younger than 2 years of age.Keywords
This publication has 28 references indexed in Scilit:
- Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practicePediatric Anesthesia, 2011
- Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 aloneBritish Journal of Clinical Pharmacology, 2010
- Mycophenolic Acid Exposure after Administration of Mycophenolate Mofetil in the Presence and Absence of Ciclosporin in Renal Transplant RecipientsClinical Pharmacokinetics, 2009
- Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United StatesJAMA, 2008
- NUCLEAR RECEPTOR EXPRESSION IN FETAL AND PEDIATRIC LIVER: CORRELATION WITH CYP3A EXPRESSIONDrug Metabolism and Disposition, 2006
- Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and ChildrenClinical Pharmacokinetics, 2006
- Ontogeny of Hepatic and Renal Systemic Clearance Pathways in InfantsClinical Pharmacokinetics, 2002
- Effect of Phenobarbital Administration on Theophylline Clearance in Premature NeonatesTherapeutic Drug Monitoring, 1990
- The effect of phenobarbital on theophylline disposition in children with asthmaJournal of Allergy and Clinical Immunology, 1985
- Effect of phenobarbital on theophylline dispositionJournal of Allergy and Clinical Immunology, 1978